Acquired Epidermodysplasia Verruciformis in the Setting of Renal Transplant

Am J Dermatopathol. 2021 Jan 1;43(1):71-74. doi: 10.1097/DAD.0000000000001696.

Abstract

Epidermodysplasia verruciformis (EV) is a rare dermatologic condition that is clinically characterized by flat, cutaneous, verrucous papules, pityriasis versicolor-like lesions, and similar lichenoid papules. There are 2 forms of EV: a classic inherited genodermatosis and a secondary acquired form. EV predisposes individuals to infections with certain types of human papillomavirus virus and subsequently increases the risk of cutaneous squamous cell carcinoma. The acquired form occurs in immunosuppressed patients, particularly in patients infected with HIV; however, it has also been described in patients who have undergone stem cell and solid organ transplantation. We report an additional case of renal transplantation and immunosuppressive therapy-associated acquired EV (AEV) in a 78-year-old man with multiple flesh-colored to violaceous, flat-topped papules distributed on the face and trunk clinically mimicking lichen planus. Biopsy was typical for that of EV, demonstrating enlarged keratinocytes with a blue-gray cytoplasm, a thickened granular layer, acanthosis, and hyperkeratosis. Herein, we discuss an unusual presentation of an AEV-mimicking lichen planus with review of the literature.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acitretin / therapeutic use
  • Adult
  • Aged
  • Biopsy
  • Diagnosis, Differential
  • Epidermodysplasia Verruciformis / diagnosis
  • Epidermodysplasia Verruciformis / drug therapy
  • Epidermodysplasia Verruciformis / immunology
  • Epidermodysplasia Verruciformis / virology*
  • Female
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation / adverse effects*
  • Lichen Planus / diagnosis
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Acitretin